Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -82777.81x is 669% below its 5-year average of -10760.15x, near the high end of its 5-year range (-441879.82x–-697.58x).
659.13% below its 12-month average of -10904.34x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -10367.95x.
INTEREST COVERAGE RATIO
-82777.81x
INTEREST COVERAGE RATIO AVG TTM
-10904.34x
INTEREST COVERAGE RATIO AVG 3Y
-19568.79x
INTEREST COVERAGE RATIO AVG 5Y
-10760.15x
INTEREST COVERAGE RATIO AVG 10Y
-2285.87x
INTEREST COVERAGE RATIO AVG 15Y
-1520.96x
INTEREST COVERAGE RATIO AVG 20Y
-1432.65x
CURRENT VS TTM AVG
-659.13%
CURRENT VS 3Y AVG
-323.01%
CURRENT VS 5Y AVG
-669.30%
CURRENT VS 10Y AVG
-3521.28%
CURRENT VS 15Y AVG
-5342.48%
CURRENT VS 20Y AVG
-5677.93%
SECTOR MEDIAN · HEALTHCARE
-4.24x
median of 359 covered companies
CURRENT VS SECTOR MEDIAN
-1952206.84%
vs the sector median at left
Enveric Biosciences, Inc.
Market Cap
$6.49M
Interest Coverage Ratio
-82777.81x
TTM Avg
-10904.34x
3Y Avg
-19568.79x
5Y Avg
-10760.15x
Market Cap
$6.57M
Interest Coverage Ratio
-545.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.21M
Interest Coverage Ratio
N/A
TTM Avg
1010.31x
3Y Avg
1010.31x
5Y Avg
509.98x
Market Cap
$6.82M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.08M
Interest Coverage Ratio
-1153.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.98M
Interest Coverage Ratio
-438.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.07M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | $6.49M | -82777.81x | -10904.34x | -19568.79x | -10760.15x |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.57M | -545.69x | N/A | N/A | N/A |
| Aclarion, Inc. (ACON)vs › | $6.80M | N/A | N/A | N/A | N/A |
| Biomerica, Inc. (BMRA)vs › | $6.21M | N/A | 1010.31x | 1010.31x | 509.98x |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.82M | N/A | N/A | N/A | N/A |
| Femasys Inc. (FEMY)vs › | $6.13M | -9.30x | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.08M | -1153.85x | N/A | N/A | N/A |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.98M | -438.08x | N/A | N/A | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $7.07M | N/A | N/A | N/A | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.17M | -496.55x | N/A | N/A | N/A |
Interest Coverage
-82777.8x
Debt/Equity
0.00
Current Ratio
10.21
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -10367.95x |
| 2026-03-31 | -5390.00x |
| 2025-12-31 | -8775.69x |
| 2025-06-30 | -19083.70x |
| 2024-06-30 | -54226.60x |
| 2023-03-31 | -441879.82x |
| 2022-12-31 | -35570.30x |
| 2022-09-30 | -18366.39x |
| 2022-06-30 | -7046.05x |
| 2022-03-31 | -1158.98x |
| 2021-12-31 | -2399.93x |
| 2021-09-30 | -9505.05x |
| 2021-06-30 | -697.58x |
| 2020-12-31 | -40.95x |
| 2020-09-30 | -14.82x |
| 2020-06-30 | -23.32x |
| 2020-03-31 | -10.01x |
| 2019-12-31 | -14.25x |
| 2019-09-30 | -6.19x |
| 2019-06-30 | -9.42x |
| 2019-03-31 | -9.11x |
| 2018-12-31 | -74.07x |
| 2018-09-30 | 32.04x |
| 2018-06-30 | -5.18x |
| 2018-03-31 | -6.47x |
| 2017-12-31 | -20.79x |
| 2017-09-30 | -29.67x |
| 2017-06-30 | -21.35x |
| 2017-03-31 | -6.94x |
| 2016-12-31 | -28.41x |
| 2016-09-30 | -4.45x |
| 2016-06-30 | -3.46x |
| 2016-03-31 | -8.63x |
| 2015-09-30 | -1.08x |
| 2015-06-30 | 18.99x |
| 2006-09-30 | -109.75x |
| 2006-06-30 | -106.43x |
| 2004-09-30 | -68.28x |
| 2004-06-30 | -36.53x |
| 2004-03-31 | -73.67x |
| 2003-12-31 | -66.13x |
| 2003-09-30 | -75.10x |
| 2003-06-30 | -68.96x |
| 2003-03-31 | -221.52x |
| 2002-12-31 | -8.33x |
